The largest database of trusted experimental protocols

34 protocols using high resolution research tomograph

1

High-Resolution Brain Imaging with PET

Check if the same lab product or an alternative is used in the 5 most similar protocols
HR-PET brain imaging was done using the High-Resolution Research Tomograph (HRRT) (Siemens, Inc., Knoxville, TN), with sensitivity of 124 1,700,000 counts per second (cps)/(μCi/ml) and a spatial resolution of 2.4mm in the transaxial 125 plane.37 Approximately 10 seconds following initiation of the stress or control task, 20 mCi of radio-labeled water (H2[15O]), created in an on-site cyclotron, was injected.
+ Open protocol
+ Expand
2

Quantifying Dopamine D2/3 Receptors in CUD

Check if the same lab product or an alternative is used in the 5 most similar protocols
[11C]-(+)-PHNO was prepared as previously described (35 (link), 36 (link)). Radioactive dose, specific activity and injected mass for CUD and HC groups are listed in Table 1. PET imaging was performed on a Siemens high-resolution research tomograph (HRRT; Siemens/CTI, Knoxville, TN, USA). A transmission scan was obtained before the emission scan. PET scans (slices=207, slice separation=1.2mm, reconstructed image resolution ~3 mm) were acquired for 120 min at rest. Head motion was measured using an optical detector (Vicra, NDI Systems, Waterloo, Ontario, Canada). MR images were collected on a Siemens 3T Trio system (Siemens Medical Solutions, Malvern, PA) using a magnetization prepared rapid acquisition gradient echo (MPRAGE) sequence (repeat time (TR)/echo time (TE)=2530/3.34, flip angle=7°, in-plane resolution=0.98×0.98 mm, matrix=256×256, slice thickness=1mm, slices=176).
+ Open protocol
+ Expand
3

PET Imaging of LRRK2 Mutation in Parkinson's

Check if the same lab product or an alternative is used in the 5 most similar protocols
Original data included in this study were obtained from the Brain Research Centre, University of British Columbia. A total of 35 subjects were considered and consisted of healthy controls (11 subjects, 4 MABs and 7 HABs), G2019S LRRK2 mutation carriers without Parkinson’s disease (PD) symptoms (8 subjects, 5 MABs and 3 HABs) and 16 subjects diagnosed with PD (16 subjects, 7 Sporadic- and 4 LRRK2-PD in MABs and 2 sporadic- and 2 Lrrk2-PD in HABs). PET scan was completed in conjunction with MRI scan on each subject. The PET scans were performed on the Siemens High-Resolution Research Tomograph (HRRT) at the UBC PET Imaging Centre. 11C-PBR28 data were acquired for 120 min in list mode after 60 sec bolus venous injection of 700 ± 73 MBq (18.9 ± 1.9 mCi) of 11C-PBR28 and then reconstructed into a dynamic sequence of images (4 × 1 min, 3 × 2 min, 8 × 5 min, 7 × 10 min) using 3D ordinary Poisson-ordered subset expectation maximization (OP-OSEM) algorithm [35 ]. All PET data were corrected for dead time, attenuation, scatter, random events and normalization. Each subject also underwent a T1weighted anatomical magnetic resonance imaging (MRI) scan, performed on a 3T Philips Achieva camera (repetition time (TR) = 0.81 milliseconds, echo time (TE) = 8.1 milliseconds and the flip angle = 8). The acquisition matrix measures 256 × 256 × 170, and the FOV measures 50 cm.
+ Open protocol
+ Expand
4

Radiosynthesis and PET Imaging of [11C]-(+)-PHNO

Check if the same lab product or an alternative is used in the 5 most similar protocols
[11C]-(+)-PHNO was prepared by N-acylation of the despropyl precursor with [11C]-propionyl chloride followed by reduction of the resulting amide with lithium aluminum hydride and purification by reverse-phase high-performance liquid chromatography (HPLC) (Wilson et al. 2005 (link)). All scans were 120 min, following a single bolus injection of [11C]-(+)-PHNO. Data were acquired on a Siemens High-Resolution Research Tomograph (HRRT, Siemens/CTI, Knoxville, TN). Data were acquired in list mode, reconstructed using the MOLAR algorithm (Carson et al. 2003 ) including correction for subject motion using an optical detection system (Vicra, NDI Systems, Waterloo, Ontario, Canada) and binned into a sequence of 33 frames of increasing duration (6 × 30 s, 3 × 1 min, 2 × 2 min, 22 × 5 min). A T1-weighted anatomical magnetic resonance imaging (MRI) scan was acquired for each subject. Regions of interest (ROIs) were drawn individually for each subject on their MRI; they included caudate and putamen, ventral striatum, globus pallidus, thalamus, substantia nigra/ventral tegmental area, and cerebellum as a reference tissue. Left and right sides were averaged. PET data were coregistered to subjects’ MRIs; ROIs were applied to the coregistered PET images. Time activity curves were generated as the average ROI activity in each frame.
+ Open protocol
+ Expand
5

Synthesis and PET Imaging of [11C]ABP688

Check if the same lab product or an alternative is used in the 5 most similar protocols
3-(6-methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-O-11C-methyloxime ([11C]ABP688) was synthetized as previously described (Elmenhorst et al., 2010 (link)). Images were acquired in the Siemens ECAT EXACT HR + scanner for 7 patients and 7 controls [approximate resolution, 6 mm full width at half maximum (FWHM)]. The remaining subjects (10 patients and 26 controls) were scanned in the Siemens High Resolution Research Tomograph (HRRT, approximate resolution of 3 mm FWHM). A 7-minute transmission scan was performed for attenuation correction, followed by a 1-hour dynamic emission scan, which began concurrently with the slow bolus injection of [11C]ABP688 (injected dose/activity = 356.7 ± 25.2 MBq; specific activity = 13.6 ± 6.3 GBq/μmol, unavailable for 10 of the controls). Data was acquired in 3D list mode and reconstructed by filtered back-projection. The reconstructed time-series was 128 × 128 × 63 voxels (2.45 mm pixels) for the HR + and 256 × 256 × 207 voxels (1.21875 mm pixels) for the HRRT. To combine data from the 2 PET scanners, HRRT images were blurred with an anisotropic Gaussian kernel of 5.7 × 5.7 × 6.7 mm FWHM.
+ Open protocol
+ Expand
6

Multimodal PET Imaging of Amyloid and Tau

Check if the same lab product or an alternative is used in the 5 most similar protocols
All eight participants had baseline 18F-AZD4694 and 18F-THK5351 PET scans to quantify brain amyloid and PHF load, respectively. A second 18F-THK5351 scan was conducted 1 week later, 1 h after an oral dose of 10 mg selegiline. Participants were also invited to undergo an optional third 18F-THK5351 PET scan 10 days after the selegiline administration. Each 18F-THK5351 acquisition consisted of dynamic images (4 × 5 min) acquired at 50–70 min after intravenous bolus injection. The mean ± standard deviation injected radioactivity of 18F-THK5351 was 6.6 ± 0.3 mCi for the baseline scan, 6.7 ± 0.4 mCi for the post-selegiline scan, and 6.9 ± 0.4 mCi for the third scan. 18F-AZD4694 acquisition consisted of dynamic images (6 × 5 min) acquired at 40–70 min after intravenous bolus injection of 18F-AZD4694. The injected radioactivity of 18F-AZD4694 was 6.3 ± 0.3 mCi. A 6-min transmission scan was acquired at the end of each PET scan. All PET scans were performed using the Siemens High Resolution Research Tomograph (HRRT). A magnetic resonance imaging (MRI) anatomical scan was also performed for all patients using the 1.5 T Siemens Sonata scanner for co-registration purposes.
+ Open protocol
+ Expand
7

HR-PET Brain Imaging in Stress Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
High Resolution-Positron Emission Tomography (HR-PET) brain imaging was conducted using the High Resolution Research Tomograph (HRRT) (Siemens, Inc., Knoxville, TN), with a spatial resolution of 2 mm (43 ). Brain perfusion was investigated by quantifying the regional activation in response to both stressful and control tasks. Ten seconds into each HR-PET scan, 20 mCi of radio-labeled water (H2[O15]), was injected to measure blood perfusion within the brain. Each scan lasted for approximately two minutes and electrocardiogram and vital signs were continuously monitored with physician present. A total of eight brain scans were performed for each individual with two scans during each of the 2 control (counting aloud and recalling a neutral event) and 2 scans for the stress (arithmetic and public speaking) conditions.
+ Open protocol
+ Expand
8

Radiolabeled Siglec-9 Receptor Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals and NAPTM columns (GE Healthcare) were acquired from Sigma-Aldrich (St. Louis, MO, USA). NOTA-Siglec-9 precursor was obtained from Peptide Specialty Laboratories (Heidelberg, Germany) as a custom synthesis. 68Ga was obtained from a 68Ge/68Ga generator (Eckert & Ziegler, Valencia, CA, USA) by elution with 0.1 M HCl. Traceselect water (Honeywell, Morristown, NJ, USA) was used for radiosynthesis. [18F]-Fluoride was produced with a cyclotron. A High-Resolution Research Tomograph (HRRT, Siemens, Knoxville, TN, USA) was used for PET imaging. A Wizard γ-counter (1480 Wizard 3”, PerkinElmer/Wallac, Turku, Finland) was used for radioactivity counting for ex vivo tissue samples.
+ Open protocol
+ Expand
9

Synthesis and PET Imaging of [11C]ABP688

Check if the same lab product or an alternative is used in the 5 most similar protocols
[11C]ABP688 was synthetized using the same methodology as in our previous studies (Elmenhorst et al. 2010 (link); DuBois et al. 2016 (link)). [11C]ABP688 was administered as a slow bolus injection through an intravenous line at the antecubital region (injected dose/activity = 356.7 ± 25.2 MBq; specific activity = 13.6 ± 6.3 GBq/μmol, unavailable for 10 of the controls). Immediately following injection, a 1-h dynamic emission scan was acquired in 3D list mode.
Six patients and 7 controls were scanned in the Siemens ECAT EXACT HR+ scanner [approximate resolution, 6 mm full width at half maximum (FWHM)]. The remaining subjects (4 patients, 26 controls) were scanned with the Siemens High Resolution Research Tomograph (HRRT, approximate resolution of 3 mm FWHM).
After correction for attenuation, scatter, and decay, data were reconstructed by filtered back-projection. The reconstructed time-series was 128 × 128 × 63 voxels (2.45 mm pixels) for the HR+ and 256 × 256 × 207 voxels (1.21875 mm pixels) for the HRRT.
To combine data from both scanners, the HRRT images were blurred with an anisotropic Gaussian kernel of 5.7 × 5.7 × 6.7 mm FWHM, based on findings from an in-house phantom study (unpublished data). The anisotropic Gaussian kernel used here was similar to previously published methods using an isotropic Gaussian kernel of 6 mm FWHM (van Velden et al. 2009 (link)).
+ Open protocol
+ Expand
10

Amyloid PET Imaging Across Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
A smaller subset of participants underwent amyloid PET ([18F]Florbetapir/AV45) on a Siemens Biograph 64 at Columbia University (voxel size=1x1x2mm3, reconstruction = OSEM3D+TOF, n = 10), on a Siemens Biograph mMR at MGH (voxel size = 2.1x2.1x2.0mm3, reconstruction = OP-OSEM, n = 31), or a Siemens high resolution research tomograph (HRRT) at UC-Irvine (voxel size =1.2x1.2x1.2mm3, reconstruction = OP-OSEM3D, n = 30), using the ADNI protocol (4x5 min frames; 50–70 min post-injection) [39 (link)], and correcting for attenuation, radioactive decay, detector normalization, randoms, and scatter. Using FreeSurfer (v 6.0) defined regions [40 (link)], standard uptake value ratios (SUVRs), with and without partial volume correction (PVC; PETSurfer [41 (link)]), were calculated in PET native space using the cerebellar gray matter as reference region for the cortex (weighted average of anterior cingulate, frontal cortex, parietal cortex, precuneus, and temporal cortex, according to Thal phasing of amyloid deposition in late-onset AD [42 (link)]) and the striatum alone due to its early amyloid accumulation in adults with DS [43 ,44 ].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!